Before We Start
Why "positive" and "negative" don't mean good and bad
In schizophrenia, "positive" symptoms mean an ADDITION of something not normally present — hallucinations, delusions, disorganized thinking. "Negative" symptoms mean a LOSS or reduction of something normally present — flat affect, lack of motivation, reduced speech. Neither word is a value judgment; they describe whether the symptom is something added to, or subtracted from, normal functioning.
💡 Why This Distinction Drives Treatment Decisions
Different antipsychotic medications have different effectiveness profiles for positive versus negative symptoms — this is one of the most clinically important reasons the distinction matters, not just an academic classification.
Mnemonic
Positive symptoms and the FLAT negative symptom mnemonic
Positive Symptoms
An excess of normal functions
Hallucinations (auditory is most common — "hearing voices"), delusions (fixed false beliefs — paranoid/persecutory delusions are most common), disorganized thinking and speech (word salad, loose associations between ideas), disorganized behavior, and catatonia.
F — Flat Affect
Negative Symptom
Reduced emotional expression — a face and voice that convey little emotional range, even when the patient may be experiencing emotion internally.
L — Alogia
Negative Symptom
Poverty of speech — reduced amount and content of spontaneous speech.
A — Avolition
Negative Symptom
Lack of motivation to initiate or complete goal-directed activities — not laziness, but a genuine symptom of the illness affecting drive.
T — Anhedonia
Negative Symptom
Inability to feel pleasure from activities that would normally be enjoyable. Social withdrawal frequently accompanies this cluster of negative symptoms as well.
💊 Negative symptoms are often mistaken by families or even new clinicians for depression or simple lack of effort — recognizing them as a distinct, biologically-based symptom cluster of schizophrenia itself (not laziness or sadness) shapes a more accurate, compassionate care approach.
Treatment
Typical vs. atypical antipsychotics
Typical (1st Generation)
Example: haloperidol (Haldol)
Effective primarily for positive symptoms. Carries a higher risk of extrapyramidal symptoms (EPS) — movement-related side effects covered in their own dedicated lesson.
Atypical (2nd Generation)
Examples: risperidone, olanzapine, quetiapine
Fewer EPS side effects, and generally more effective against negative symptoms compared to typical antipsychotics — but carry a meaningful risk of metabolic side effects (weight gain, elevated blood glucose, dyslipidemia), which require their own ongoing monitoring.
Clozapine — The Special Case
Reserved specifically for treatment-resistant schizophrenia
Clozapine is often the most effective antipsychotic overall, but it's reserved as a later-line option because of a serious risk of agranulocytosis (a dangerous drop in white blood cells that severely compromises infection-fighting ability) — patients on clozapine require weekly complete blood count (CBC) monitoring, particularly early in treatment.
🏥 Clinical Scenario — Distinguishing Negative Symptoms From Depression
A patient with schizophrenia shows flat affect, minimal speech, and appears to have lost interest in activities they previously enjoyed. A new nurse wonders if the patient might also be depressed.
Consider Both Possibilities
Flat affect, reduced speech, and anhedonia could reflect the negative symptoms of schizophrenia itself, a co-occurring depressive episode, or in some cases medication side effects — these presentations can overlap significantly. Rather than assuming one explanation, a fuller assessment (including mood-specific screening questions, medication review, and symptom timeline) is needed to differentiate them.
Why the Distinction Matters
If these are negative symptoms of schizophrenia rather than a separate depressive episode, treatment approaches differ — an atypical antipsychotic already targeting negative symptoms may already be addressing this, whereas a true co-occurring depression might need additional, separate treatment. Accurately identifying the source of the symptom shapes what happens next in the care plan.
📌 NCLEX Application
Schizophrenia questions test both symptom classification and medication safety:
Symptom classification: "Which of the following is a negative symptom of schizophrenia: hallucinations, avolition, delusions, or disorganized speech?" → Avolition — the other three are all positive symptoms.
Medication monitoring: "A patient is started on clozapine. What specific lab monitoring is required, and why?" → Weekly CBC, due to the risk of agranulocytosis.
Treatment matching: "Which class of antipsychotics is generally more effective for negative symptoms?" → Atypical (2nd generation) antipsychotics.
⚠️ The Trap — Assuming Negative Symptoms Reflect Poor Motivation or Personal Choice
Because negative symptoms look, on the surface, like disinterest or low effort, they can be mistakenly attributed to the patient's attitude or choices rather than recognized as a genuine, biologically-rooted symptom cluster of the illness itself. This misunderstanding can lead to frustration, stigma, or inappropriate care approaches (like simply encouraging the patient to "try harder").
The safeguard: Recognize avolition, alogia, flat affect, and anhedonia as legitimate symptoms of schizophrenia requiring clinical management — not as character traits or choices within the patient's control.
✓ Quick Self-Test
Answer before checking:
1. What does the FLAT mnemonic stand for?
2. Name two positive symptoms of schizophrenia.
3. Why is clozapine reserved for treatment-resistant cases despite being highly effective?
4. Which class of antipsychotics carries more risk of EPS, and which carries more risk of metabolic side effects?
Answers:
1. Flat affect, aLogia, Avolition, anhedonia (with social withdrawal also often included).
2. Hallucinations, delusions (disorganized speech/behavior and catatonia are also correct).
3. Because of its risk of agranulocytosis, requiring weekly CBC monitoring — this makes it a later-line option despite strong effectiveness.
4. Typical (1st generation) antipsychotics carry more EPS risk; atypical (2nd generation) antipsychotics carry more metabolic risk.
Next Lesson
The Four Levels of Anxiety
→